Search

everythinglearnresearchcommunity

for

Search:↓

GnRH treatment can reduce breast cancer cell invasion.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

GnRH agonist effectively diagnoses and treats postmenopausal hyperandrogenism from ovarian sources.

The combination therapy reduced hirsutism in women with PCOD and was well-tolerated.

Removing both ovaries treated the woman's excess male hormone symptoms.

Ciclosporin can cause excessive hair growth even with testosterone blockers.

Goserelin injections can effectively manage hyperandrogenism symptoms in postmenopausal women who can't have surgery.

Ovarian hyperthecosis should be considered in young women with severe male-like symptoms and can be managed with hormone treatments.

Low prolactin levels in PCOS can cause metabolic problems like insulin resistance and obesity.

A multidisciplinary approach is crucial for safe and effective hormone treatment in gender-dysphoric individuals, with specific guidelines for adolescents and adults.

ADT for prostate cancer may harm the heart, but GnRH antagonists might be safer.

The document concludes that treatment for excessive hair growth depends on the cause, with options including hair removal methods and medications like anti-androgens or insulin-sensitizing drugs.

Hirsutism in women often indicates health issues like polycystic ovarian syndrome and is treated with lifestyle changes, medication, and cosmetic measures.

Choose treatments for sex offenders based on individual needs, using hormonal and nonhormonal options to reduce sexual drive.

GnRH-a or orchiectomy is more effective than anti-androgens for managing hormone levels in transgender women.

Using GnRHa agonists helps diagnose and treat ovarian hyperthecosis when surgery isn't possible.

Effective treatment for skin issues in women with PCOS includes oral contraceptives, antiandrogens, and other medications and procedures.

Monitoring for adverse effects in clinical treatments is crucial.

Ovarian stromal hyperplasia can cause high testosterone in postmenopausal women and is treated by removing the ovaries.

DHT reduces a cell's ability to promote hair growth, while 3D culture without DHT improves it.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

GnRH analogue can help diagnose ovarian causes of high testosterone in postmenopausal women when scans don't show the cause.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

Buserelin safely and effectively suppresses early puberty, potentially improving final height.

Some antiandrogens may lower testosterone better than others, but it's unclear which is best for feminization in transgender women; more research is needed.

Medical castration in prostate cancer patients can increase the risk of serious heart rhythm problems, so it's important to monitor heart activity during treatment.

Loop diuretics may double bone loss in elderly men, finasteride lowers prostate cancer risk but may increase high-grade tumors, abarelix reduces testosterone quickly, and transdermal testosterone offers minimal sexual benefit for women.

Deslorelin implant successfully regrew hair in a female Pomeranian with alopecia X.

The study found three different timing patterns of symptoms in women with premenstrual dysphoric disorder.

Deslorelin effectively treats hair loss in neutered ferrets by reducing hormone levels.